Stay updated on Pembrolizumab Combo in Resectable NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Resectable NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Resectable NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Publication added under Publications: A Subgroup Analysis of Perioperative Pembrolizumab in Clinical Stage II NSCLC from KEYNOTE-671. Eur J Cardiothorac Surg. 2026 Mar 10; 68(3): ezag028.
    Difference
    0.0%
    Check dated 2026-04-02T00:13:38.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Added Naples, Campania, Italy, 80131 and removed Napoli, Campania, Italy, 80131 from the locations list.
    Difference
    0.0%
    Check dated 2026-03-25T20:35:22.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.0 at the top, replacing Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T16:45:39.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision: v3.4.3 updated from v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T11:21:51.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the funding-lapse notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-11T01:49:49.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a government funding notice about NIH operations and updated the site revision to v3.4.1, replacing v3.4.0.
    Difference
    0.1%
    Check dated 2026-02-03T23:01:22.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Resectable NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Resectable NSCLC Clinical Trial page.